We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Harmonization Could Lead to Product Withdrawals, Consultant Says
Harmonization Could Lead to Product Withdrawals, Consultant Says
June 14, 2006
The FDA’s move to harmonize its approach to risk management with its European counterparts could prove too expensive for many pharmaceutical companies to handle, potentially leading some products to be withdrawn from the market, an industry consultant said.